Daxor Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DXR, updated each market day.
DXR AI Sentiment
AI predicts Daxor Corporation Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Daxor Corporation Common Stock
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
Sector
Exchange
Market Cap
$67,898,545
Cap Tier
Employees
750
Headquarters
NEW YORK, NY
Listed Since
July 25, 1983
Website
DXR Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DXR Volatility
Daxor Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
